Research

5-Amino-1MQ

Scientific Research on 5-Amino-1MQ

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small molecule belonging to the class of methylquinolinium derivatives. Structurally, it is characterized by a quinolinium core with an amino substitution at position 5 and a methyl group at position 1. This compound has been widely investigated in preclinical research due to its specific interaction with enzymes involved in cellular metabolism.

Experimental studies identify 5-Amino-1MQ as a selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme associated with metabolic, epigenetic, and cellular energy processes.

Mechanism of Action and NNMT Inhibition

The primary mechanism investigated for 5-Amino-1MQ involves the inhibition of NNMT, an enzyme responsible for the methylation of nicotinamide. This pathway directly influences NAD⁺ (nicotinamide adenine dinucleotide) metabolism, an essential cofactor for redox reactions, DNA integrity maintenance, and regulation of gene expression.

Suppression of NNMT activity has been associated with significant changes in interconnected metabolic pathways, including:

• Regulation of cellular redox balance
• Epigenetic modulation through histone methylation
• Influence on intracellular metabolic efficiency

In preclinical models, exposure of murine adipocytes to 5-Amino-1MQ resulted in a concentration-dependent increase in intracellular NAD⁺ levels, suggesting a direct impact on metabolic homeostasis and cellular function.

Investigated Metabolic Impacts

In the context of metabolic disorder research, 5-Amino-1MQ has been evaluated in experimental models of diet-induced obesity. Data indicate consistent reductions in body weight, white adipose tissue mass, and adipocyte size, without significant changes in food intake.

These findings suggest that the observed metabolic effects are not related to appetite suppression, but rather to the direct modulation of pathways associated with lipogenesis and energy storage. This profile makes 5-Amino-1MQ a compound of interest in research focused on energy metabolism and experimental obesity.

Investigation in Oncological Models

Beyond metabolic applications, 5-Amino-1MQ has been studied in preclinical oncological research, particularly due to its influence on cellular epigenetic and energy mechanisms.

In studies involving cancer-associated fibroblasts (CAFs), NNMT inhibition by 5-Amino-1MQ demonstrated:

• Changes in histone methylation patterns
• Reduction in tumor-supporting metabolic activity
• Modulation of the tumor microenvironment in experimental models

In animal models, these effects were associated with reduced tumor cell proliferation, positioning the compound as an object of interest in investigations focused on isolated or combined experimental strategies.

Pharmacokinetic Considerations in Research

From a pharmacological perspective, 5-Amino-1MQ exhibits good cellular permeability, a characteristic that supports its use in various experimental models. However, aspects related to metabolic stability, tissue distribution, and elimination remain under investigation.

Additional in vitro and in vivo studies are necessary to further understand its pharmacokinetic and pharmacodynamic profile, particularly regarding tissue selectivity and minimization of off-target effects.

Final Considerations

5-Amino-1MQ represents a compound of high interest in contemporary scientific research, especially in studies related to energy metabolism, epigenetic regulation, and tumor biology. Its role as a selective NNMT inhibitor positions it as a valuable tool for investigating complex metabolic and cellular mechanisms.

The use of 5-Amino-1MQ remains restricted to research purposes, and it is essential that any investigation follows rigorous scientific protocols and applicable regulatory standards.

References

Conlon, N., & Ford, D. (2022). A systemic approach to NAD⁺ restoration... Biochemical Pharmacology, 114946. https://doi.org/10.1016/j.bcp.2022.114946

Myong, S., Nguyen, A., & Challa, S. (2024). Biological functions and therapeutic potential of NAD⁺ metabolism in gynecologic cancers. Cancers, 16. https://doi.org/10.3390/cancers16173085

Li, X., Pi, Y., Chen, Y., Zhu, Q., & Xia, B. (2022). Nicotinamide N-methyltransferase: a promising biomarker and target for human cancer therapy. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.894744

Liu, J., Deng, Z., Zhu, X., Zeng, Y., Guan, X., & Li, J. (2021). Functions of nicotinamide N-methyltransferase in obesity and type 2 diabetes. BioMed Research International, 2021. https://doi.org/10.1155/2021/9924314

Scientific Reviewer

This content was reviewed by Dr. Ky H. Le, MD. Dr. Ky H. Le is a family physician based in Aiea, Hawaii. He earned his medical degree from St. George's University School of Medicine and has been practicing for over 20 years. He has expertise in the treatment of obesity, diabetes, hypertension, and high blood pressure, among other conditions. Dr. Ky H. Le accepts Medicare, Aetna, Humana, Blue Cross, and United Healthcare.

Ref.: https://health.usnews.com/doctors/ky-le-371599#expertise